TWINNING FOR EXCELLENCE TO STRATEGICALLY ADVANCE RESEARCH IN CARCINOGENESIS AND CANCER

结对卓越，战略性地推进致癌和癌症研究

• 批准号: 10050740
• 金额: $ 33.02万
• 依托单位: SWANSEA UNIVERSITY
• 依托单位国家: 英国
• 项目类别: EU-Funded
• 财政年份: 2023
• 资助国家: 英国
• 起止时间: 2023 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10050740
• 关键词: TWINNING; EXCELLENCE; STRATEGICALLY; ADVANCE; RESEARCH

The CutCancer project aims to strengthen and increase the research and innovation capacity and excellence of the National institute of Biology (NIB) in Slovenia. This will be achieved through targeted twinning activities with three internationally renowned institutions; Swansea University from the UK, Stockholm University from Sweden and VU Medical Centre Amsterdam from the Netherlands, all of which poses specific, unique and complementary knowledge and expertise that is highly desired and needed at NIB. Together with ongoing substantial infrastructural improvements and significant research equipment upgrades, CutCancer will enable implementation of cutting-edge approaches and methodologies (including advanced in vitro 3D cell models, spatial and single-cell analyses), facilitating frontier research in the field of preclinical 3D cancer research. CutCancer will encompass the development of synergies between research institutions, fostering networking and participation in future Research and Innovation processes. CutCancer aims to go beyond the purely scientific aspects and raise the management and administrative capacity of NIB to reach top level. Twinning activities will include specific hands-on training, expert visits, webinars, workshops and summer schools, job shadowing and exchange of best practices, targeting strategically selected research and administrative areas. Results will be disseminated at international and regional conferences and targeted events for relevant stakeholders ranging from the scientific community to the health sector, professional networks, students and general public. The CutCancer´s strategic action plan will ensure that the project leads to long-term collaborations within the consortium and beyond. This will include future research projects coordinated by NIB, as well as the sharing of infrastructure and innovations brought by the newly implemented methods, approaches and strategies, targeted during the CutCancer project.

CutCancer项目旨在加强和提高斯洛文尼亚国家生物研究所（NIB）的研究和创新能力。这将通过与三个国际知名机构有针对性的结对活动来实现;来自英国的斯旺西大学，来自瑞典的斯德哥尔摩大学和来自荷兰的阿姆斯特丹VU医疗中心，所有这些都构成了NIB高度期望和需要的特定，独特和互补的知识和专业知识。随着基础设施的不断改善和研究设备的重大升级，CutCancer将能够实施尖端的方法和方法（包括先进的体外3D细胞模型，空间和单细胞分析），促进临床前3D癌症研究领域的前沿研究。CutCancer将包括研究机构之间的协同作用的发展，促进网络和参与未来的研究和创新过程。CutCancer旨在超越纯粹的科学方面，提高NIB的管理和行政能力，达到顶级水平。结对活动将包括具体的实践培训、专家访问、网络研讨会、讲习班和暑期学校、职业跟踪和交流最佳做法，目标是战略性选定的研究和行政领域。将在国际和区域会议上以及针对科学界、卫生部门、专业网络、学生和公众等利益攸关方的有针对性的活动中传播成果。CutCancer的战略行动计划将确保该项目导致联盟内外的长期合作。这将包括由NIB协调的未来研究项目，以及在CutCancer项目期间针对新实施的方法，方法和战略所带来的基础设施和创新的共享。